Özgür YİĞİT, Berrin İNANÇ, Kubilay İNANÇ, Suat BİLİCİ, Mustafa ÇAKIR

The Effects of Adjuvant Chemoradiotherapy on Survival in Patients with Primary Laryngeal Cancer with Close Surgical Margins and Positive Surgical Margins

OBJECTIVEThe gold standard treatment for squamous cell carcinoma of the larynx is a resection of the primary tumour with negative surgical margins. In this study, we retrospectively investigated the effects of ad-juvant concurrent chemoradiation on the survival rates of laryngeal cancer with close surgery margins and patients with positive surgery margin.METHODSA total of 40 patients treated with concurrent chemoradiation were included in this study. All of these patients had surgery for laryngeal cancer and had received 66 Gy (2Gy/fr) of radiotherapy and con-current weekly cisplatin. Patients were stratified into two groups according to surgical margin status. Members of group 1 had a positive surgery margin; group 2 patients had close surgical margins and were studied for comparative analyses.RESULTSAt the median follow-up of 40 months, nine patients (44.4%) experienced local/regional failures, six of which were detected on the second follow-up. In patients with positive surgical margin, overall survival (OS), disease-free survival (DFS), and loco-regional progression-free survival (LRPFS) were 59%, 44% and 81%, respectively. OS, DFS and LRPFS for those with close surgical margins were 57%, 46% and 71%, respectively. No statistically significant differences related to OS, DFS, and LRPFS were observed between groups 1 and 2 (p=0.802, p=0.610 and p=0.383, respectively). On univariate Cox-regression analysis, the presence of perineural invasion and lymphovascular invasion was statistically significant for OS and DFS (p=

PDF

___

1. Shang J, Gu J, Han Q, Xu Y, Yu X, Wang K. Chemoradiotherapy is superior to radiotherapy alone after surgery in advanced squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Int J Clin Exp Med 2014;7(9):2478–87.
2. Bernier J1, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, et al. Postoperative Irradia tion with or without concomitant chemotherapy for locally dvanced head and neck cancer. N Engl J Med. 2004;350(19):1945–52.
3. Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2003;32(1):30–4.
4. Al-Sarraf M. Treatment of locally advanced head and neck cancer: Historical and critical review. Cancer Control 2002;9(5):387–99.
5. Shah JP, Cendon RA, Farr HW, Strong EW. Carcinoma of the oral cavity. Factors affecting treatment failure at the primary site and neck. Am J Surg 1976;132(4):504–7.
6. Edge S, Byrd DR, Conpton CC, Fritz AG, Grene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York, USA: Springer Verlag; 2010.
7. Prescribing, recording and reporting photon-beam intensity-modulated radiation therapy IMRT. International Commission on Radiation Units and Measurements (ICRU) 2010;10(1):83.
8. Brizel DM, Esclamado R. Concurrent chemoradiotherapy for locally advanced, nonmetastatic squamous carcinoma of the head and neck: consensus, controversy, and conundrum. J Clin Oncol 2006;24(17):2612–7.
9. Looser KG, Shah JP, Strong EW. The significance of positive margins in surgically resected epidermoid carcinomas. Head Neck Surg 1978;1(2):107–11.
10. Batsakis JG. Surgical excision margins: a pathologist’s perspective. Adv Anat Pathol. 1999;6(3):140–8.
11. Smid L, Budihna M, Zakotnik B, Soba E, Strojan P, Fajdiga I, et al. Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 2003;56(4):1055–62.
12. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Radiation Therapy Oncology Group 9501/ Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 2004;350(19):1937–44.
13. Brizel DM, Esclamado R. Concurrent chemoradiotherapy for locally advanced, nonmetastatic squamous carcinoma of the head and neck: consensus, controversy, and conundrum. J Clin Oncol 2006;24(17):2612–7.
14. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers:a comparative analysis of concurrent postoperative radiation plus chemotheraphy trials of the EORTC(22931) and RTOG(9501). Head Neck 2005;27(10):843–50.
15. Zanoni DK, Migliacci JC, Xu B, Katabi N, Montero PH, Ganly I, et al. A proposal to revisit the definition of close margin is squamous cell carcinoma of oral tongue. JAMA Otolaryngol Head Neck Surg 2017;143(6):555–60.